Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

UniCar Closes C Funding for “Safe” CAR-T Dual Target Candidate

publication date: Aug 29, 2022

Shanghai UniCar Therapy closed a Series C financing to advance clinical trials of its ssCART-19 injection in patients with leukemia. Guan Bang Fund and Junci Investment were the two named investors in the C round. UniCar’s ssCART-19 injection, the company’s lead CAR-T 2.0, expresses single-chain antibodies targeting CD19 and IL-6 silencing elements (shRNA). The company expects IL-6 silencing will decrease cytokine release syndrome in patients. UniCar focuses on refining CAR-T products to increase their efficacy. The company said the C round raised “tens of millions of RMB.” More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here